February 2016 – The CenterWatch Monthly : PDF
CROs begin consolidating site landscape
Major trends in drug development will reshape the global investigative site landscape. Trends to look out for include patient centricity and big data to CROs assuming responsibility for site effectiveness and patient recruitment.
Realities of Precision Medicine
As biopharmaceutical companies increase R&D investment in precision medicine, a trend that is expected to rise by one-third in the next five years, clinical research professionals will need to implement operating practices and processes that can meet the complex demands of an individualized approach to drug development.
Also in this issue:
- Putting patients’ and families’ needs first can increase trial enrollment, reduce delays
- Leaner, simpler approach to clinical research needed
- Regulatory Update
- Month in Review
- FDA Actions
- Study Lead Opportunities
- New Drugs in the Pipeline